241 related articles for article (PubMed ID: 27586275)
1. Identification of pyrrolo[3,2-c]pyridin-4-amine compounds as a new class of entry inhibitors against influenza viruses in vitro.
Chang SY; Cruz DJ; Ko Y; Min JY
Biochem Biophys Res Commun; 2016 Sep; 478(4):1594-601. PubMed ID: 27586275
[TBL] [Abstract][Full Text] [Related]
2. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
[TBL] [Abstract][Full Text] [Related]
3. A natural component from Euphorbia humifusa Willd displays novel, broad-spectrum anti-influenza activity by blocking nuclear export of viral ribonucleoprotein.
Chang SY; Park JH; Kim YH; Kang JS; Min JY
Biochem Biophys Res Commun; 2016 Mar; 471(2):282-9. PubMed ID: 26850850
[TBL] [Abstract][Full Text] [Related]
4. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.
Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir
Mishin VP; Patel MC; Chesnokov A; De La Cruz J; Nguyen HT; Lollis L; Hodges E; Jang Y; Barnes J; Uyeki T; Davis CT; Wentworth DE; Gubareva LV
Emerg Infect Dis; 2019 Oct; 25(10):1969-1972. PubMed ID: 31287050
[TBL] [Abstract][Full Text] [Related]
6. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL
J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Small Benzamide Inhibitor of Influenza Virus Using a Cell-Based Screening.
Shin WJ; Nam KY; Kim ND; Kim SH; No KT; Seong BL
Chemotherapy; 2016; 61(3):159-66. PubMed ID: 26821172
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans.
To KKW; Mok KY; Chan ASF; Cheung NN; Wang P; Lui YM; Chan JFW; Chen H; Chan KH; Kao RYT; Yuen KY
J Gen Virol; 2016 Aug; 97(8):1807-1817. PubMed ID: 27259985
[TBL] [Abstract][Full Text] [Related]
9. RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.
Lesch M; Luckner M; Meyer M; Weege F; Gravenstein I; Raftery M; Sieben C; Martin-Sancho L; Imai-Matsushima A; Welke RW; Frise R; Barclay W; Schönrich G; Herrmann A; Meyer TF; Karlas A
PLoS Pathog; 2019 Mar; 15(3):e1007601. PubMed ID: 30883607
[TBL] [Abstract][Full Text] [Related]
10. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
[TBL] [Abstract][Full Text] [Related]
11. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
[TBL] [Abstract][Full Text] [Related]
12. Ching-fang-pai-tu-san inhibits the release of influenza virus.
Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
[TBL] [Abstract][Full Text] [Related]
13. Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus.
Hussein AFA; Cheng H; Tundup S; Antanasijevic A; Varhegyi E; Perez J; AbdulRahman EM; Elenany MG; Helal S; Caffrey M; Peet N; Manicassamy B; Rong L
Antiviral Res; 2020 May; 177():104782. PubMed ID: 32222293
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins.
Du R; Cheng H; Cui Q; Peet NP; Gaisina IN; Rong L
Antiviral Res; 2021 Feb; 186():105013. PubMed ID: 33428962
[TBL] [Abstract][Full Text] [Related]
15. A "building block" approach to the new influenza A virus entry inhibitors with reduced cellular toxicities.
Lin D; Li F; Wu Q; Xie X; Wu W; Wu J; Chen Q; Liu S; He J
Sci Rep; 2016 Mar; 6():22790. PubMed ID: 26952867
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of the antiviral activity of methylglyoxal against influenza B virus infection.
Charyasriwong S; Haruyama T; Kobayashi N
Drug Discov Ther; 2016; 10(4):201-10. PubMed ID: 27558282
[TBL] [Abstract][Full Text] [Related]
17. Activity of enisamium, an isonicotinic acid derivative, against influenza viruses in differentiated normal human bronchial epithelial cells.
Boltz D; Peng X; Muzzio M; Dash P; Thomas PG; Margitich V
Antivir Chem Chemother; 2018; 26():2040206618811416. PubMed ID: 30466301
[TBL] [Abstract][Full Text] [Related]
18. Antiviral Activity of Fermented Ginseng Extracts against a Broad Range of Influenza Viruses.
Wang Y; Jung YJ; Kim KH; Kwon Y; Kim YJ; Zhang Z; Kang HS; Wang BZ; Quan FS; Kang SM
Viruses; 2018 Sep; 10(9):. PubMed ID: 30200514
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of Poncirus trifoliata seed extract against oseltamivir-resistant influenza virus.
Heo Y; Cho Y; Ju KS; Cho H; Park KH; Choi H; Yoon JK; Moon C; Kim YB
J Microbiol; 2018 Aug; 56(8):586-592. PubMed ID: 30047088
[TBL] [Abstract][Full Text] [Related]
20. Emerging antiviral strategies to interfere with influenza virus entry.
Vanderlinden E; Naesens L
Med Res Rev; 2014 Mar; 34(2):301-39. PubMed ID: 23801557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
